Michael T. Constantino 9 Meters Biopharma, Inc. (NMTR) insider trading activity

Michael T. Constantino is Director of 9 METERS BIOPHARMA, INC.. Currently has a direct ownership of 10,911 shares of NMTR, which is worth approximately $218. The most recent transaction as insider was on Mar 29, 2023, when has been sold 7,885 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.9K

0% 3M change

0% 12M change

Total Value Held $218

Michael T. Constantino Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 29 2023	BUY Grant, award, or other acquisition	-	7,885 Added 41.95%	10,911 Common Stock
May 23 2022	BUY Open market or private purchase	$7,680 $0.48 p/Share	16,000 Added 20.91%	60,508 Common Stock
Aug 24 2021	BUY Open market or private purchase	$20,520 $1.14 p/Share	18,000 Added 25.67%	52,108 Common Stock

Also insider at

HUMA

Humacyte, Inc. Healthcare

Director

MTC